A Phase 4, 6-Month Open-Label Extension Study to Evaluate the Safety, Tolerability, and Efficacy of Quillichew (Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablets (ERCT) in Children with Attention Deficit Hyperactivity Disorder
Administered By
Awarded By
Contributors
- Dew, Rachel E Principal Investigator
Start/End
- May 31, 2018 - January 16, 2019